Harborside was the first dispensary anywhere to laboratory test cannabis. After being denied service by every commercial lab in the Bay Area, Executive Director Steve DeAngelo co-founded Steep Hill Laboratory, the first lab dedicated exclusively to cannabinoid analysis. Today, Steep Hill tests cannabis for dozens of dispensaries, and is the leading innovator in the field.
Harborside testing includes both safety screening and potency analysis. Medicine that fails to pass safety screening is returned to the grower, and never provided to patients. Potency analysis measures the percentage of THC, CBD, and CBN. Summarized test results are displayed in our sample cases, and full test results are available upon request from a patient service associate.
The testing program has two main components: safety screening and potency quantification. Safety screening analyzes and detects contamination of pathogenic molds, which can threaten the health of patients with compromised immune systems. Potency quantification provides the percentages of three major cannabinoids: THC, CBD and CBN. Later stages of the program will include the use of patient surveys to develop a comprehensive database of the efficacy of medical cannabis.
Harborside Health Center patients are able to access the testing results in three ways: labels in display cases, labels on products, and a book of complete test results. Labels include percentages for THC, CBD and CBN; and are posted in medicine display cases, as well as affixed to the products themselves. A book containing complete spectrometry reports for each product is available at the service counter for those patients who desire more detailed analytical results. Testing services commenced with an initial launch period to identify and develop the logistics of sample collection and result identification.
To learn more information about the Steep Hill Lab, please visit: